Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients
Background The study investigates the relationship between Plasminogen activator inhibitor-1 (PAI-1) levels and the progression of diabetic nephropathy (DN). The fibrinolytic system is impaired in type 2 diabetes mellitus (DM), leading to elevated PAI-1 levels, increasing the potential for renal fib...
| Κύριοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Wolters Kluwer Medknow Publications
2023-07-01
|
| Σειρά: | Al-Azhar Assiut Medical Journal |
| Θέματα: | |
| Διαθέσιμο Online: | https://journals.lww.com/10.4103/azmj.azmj_22_24 |